Related Experiment Videos

[Inhibition of ras-dependent transformation by using dominant negative ras mutant N116Y]

T Yokoyama1

  • 1Department of Plastic and Reconstructive Surgery, Hokkadio University School of Medicine, Sapporo, Japan.

[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science
|May 1, 1995
PubMed

Insights

The N116Y mutant suppresses Ras-dependent cell transformation by blocking GDP/GTP exchange. ERK2 activation is not essential for Ras-mediated transformation, suggesting distinct signaling pathways for cell growth and transformation.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Context:

  • Ras p21 proteins function as molecular switches in signal transduction pathways, regulating cell growth and differentiation.
  • Ras activity is controlled by the cycling between active GTP-bound and inactive GDP-bound states, influenced by GDP/GTP exchange and GTPase activity.
  • The v-H-ras N116Y mutant exhibits dominant-negative activity, suppressing Ras-dependent phenotypes.

Purpose:

  • To investigate the impact of the N116Y mutant on Ras-mediated signals crucial for cellular transformation.
  • To construct an inducible expression system for the N116Y mutant in Ras-transformed NIH3T3 cells.
  • To elucidate the role of ERK2 phosphorylation in Ras-dependent transformation.

Summary:

  • An inducible vector expressing the N116Y mutant was created and transfected into Ras-transformed NIH3T3 cells (18A), yielding clones T1 and T6.
  • Treatment with heavy metals induced N116Y expression, causing flat reversion and inhibiting anchorage-independent growth stimulated by EGF, PDGF, or serum.
  • The N116Y mutant blocked GDP/GTP exchange but had limited effect on PDGF/serum-induced ERK2 phosphorylation, indicating ERK2 is not sufficient for Ras transformation.

Impact:

  • These findings suggest that ERK2 activation is neither necessary nor sufficient for Ras-dependent cellular transformation.
  • The study highlights a potential divergence in signal transduction pathways governing cell growth versus transformation.
  • The N116Y-suppressed signal pathway may be critical for driving cellular transformation, offering new therapeutic targets.

Related Concept Videos